Cargando…
The efficacy and safety of anti-interleukin-6 receptor monoclonal blockade in a renal transplant patient with Castleman disease: early post-transplant outcome
BACKGROUND: Multicentric Castleman disease (MCD) is an uncommon lymphoproliferative disease characterized by systemic inflammatory reactions associated with the dysregulated production of interleukin-6 (IL-6). In patients with MCD, renal involvement is uncommon, with only one report published regard...
Autores principales: | Matsunami, Masatoshi, Ubara, Yoshifumi, Sumida, Keiichi, Oshima, Yoichi, Oguro, Masahiko, Kinoshita, Kazuya, Tanaka, Kiho, Nakamura, Yuki, Kinowaki, Keiichi, Ohashi, Kenichi, Fujii, Takeshi, Igawa, Takuro, Sato, Yasuharu, Ishii, Yasuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186080/ https://www.ncbi.nlm.nih.gov/pubmed/30314457 http://dx.doi.org/10.1186/s12882-018-1065-4 |
Ejemplares similares
-
Pulmonary Manifestations of Plasma Cell Type Idiopathic Multicentric Castleman Disease: A Clinicopathological Study in Comparison with IgG4-Related Disease
por: Nishimura, Midori Filiz, et al.
Publicado: (2020) -
Retinopathy progression and the risk of end-stage kidney disease: results from a longitudinal Japanese cohort of 232 patients with type 2 diabetes and biopsy-proven diabetic kidney disease
por: Yamanouchi, Masayuki, et al.
Publicado: (2019) -
Renal-limited Cryoglobulinemic Vasculitis: Two Case Reports
por: Toriu, Naoya, et al.
Publicado: (2018) -
Hemosiderin deposition in lymph nodes of patients with plasma cell-type Castleman disease
por: Han, Yanyan, et al.
Publicado: (2020) -
Development of osmotic vacuolization of proximal tubular epithelial cells following treatment with sodium-glucose transport protein 2 inhibitors in type II diabetes mellitus patients-3 case reports
por: Watanabe, Shun, et al.
Publicado: (2021)